Baird initiated coverage of Inspire Medical with an Outperform rating and $371 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on INSP:
- Inspire Medical price target raised to $360 from $340 at Piper Sandler
- Inspire Medical price target raised to $380 from $300 at Mizuho
- Inspire Medical price target raised to $350 from $300 at Stifel
- Inspire Medical Systems, Inc. to Report Second Quarter 2023 Financial Results on August 1, 2023
- Inspire Medical price target raised to $355 from $310 at BofA